![]() |
Patents / Biotechnology / US Biotechnology Practice |
|
4.2 The Written Description Requirement Claims
that are broader than the supporting disclosure may be held to be invalid.
Thus if the claim excludes a feature that the description indicates is
essential such a claim may be invalid, particularly if the inventor admits that
he only thought of omitting the feature from the claim after seeing the
products of competitors.
[34]
In
general problems can arise as to whether this requirement was met when the
applicant amends the claims during prosecution of the application. In view of
the Federal Circuit’s view that the purpose of this requirement is to
determine whether or not the inventor had possession of the invention at the
time of filing the application, issues can arise, especially in the area of
biotechnology or other areas of technology where there is a low degree of
predictability, even with the original claims, notwithstanding the fact that
the original claims themselves are deemed to be part of the original disclosure.
[35]
In such a case, in order to comply with this requirement, it is necessary that
"the disclosure of the application relied upon reasonably conveys to the
artisan that the inventor had possession at [the time of filing] of the later
claimed subject matter".
[36]
In 1997, in
University
of California v. Eli Lilly and Co.
[37]
the Court of Appeals for the Federal Circuit affirmed a lower court decision
that a patent which included claims directed to mammalian, vertebrate and human
cDNA was invalid because there was no written description of the cDNA. The
Federal Circuit noted that a written description of DNA "requires a precise
definition, such as by structure, formula, chemical name or physical
properties". The Court stated that describing a method for preparing cDNA or
describing the protein coded for by the cDNA while describing how to make and
use the cDNA did not meet the written description requirement. A prior decision
in
Fiers v. Sugamo [38]
held that:
"An adequate description of DNA requires more than a mere statement that it is part of the invention and reference to a potential method of isolating it; what is required is a description of the DNA itself". The
moral to be drawn from these cases is that when drafting one's application one
should try to ensure that basis has been provided for as many different ways of
claiming the invention as possible, for example by providing bases for claiming
subgeneric groupings and sub combinations of integers so that if one ever needs
to fall back to claims for such limited views of the invention one can point to
a specific written description of them in the original text.
[34]
The Gentry Gallery Inc. v. The Berkline Corp.,
45 USPQ2d 1498. This case has given rise to much comment and has been referred
to as creating a "missing element rule" which has apparently led to some
district courts giving very restricted interpretations to patents holding valid
only those that claim the preferred embodiments. It seems clear, however, that
this was not what the Federal Circuit intended. In
Johnson Worldwide Associates Inc. v. Zebco Corp,
50 USPQ2d 1607, the Court distinguished Gentry, pointing out that in that case
the specification had given a particular location of an element as being "the
only possible location" and stating that in Gentry "the patent's disclosure
makes crystal clear that a particular (i.e. narrow) understanding of a claim
term is an essential element of the inventor's invention”. The issue was
also considered by the Northern District of California in
Reiffin v. Microsoft Corp,
59 USPQ2d 1421, which deduced, from a concurring opinion of Judge Newman in a
prior consideration of other aspects of the case by the Federal Circuit (54
USPQ2d 1915), that there was no such thing as an omitted element rule.
[35]
In
re Koller, 613 F.2d 819 204 USPQ 702 (CCPA 1980);
In
re Smith, 481 F.2d 910, 178 USPQ 629 (CCPA 1973).
[36]
Wang Labs Inc. v. Toshiba Corp.,
993 F.2d 858, 26 USPQ2d 1767.
[37]
43 USPQ2d 1398.
|
![]() |
![]() |
[Home] [About Ladas & Parry LLP]
[Contact Us] [Search]
[Trademarks] [Domain Names
& E-Commerce] [Patents & Copyrights]
[Litigation] [IP Rights
Maintenance] [IP as Property] [News
& Bulletins]
© Copyright 2002 John Richards - Posted July 2002
Please read our disclaimer.